http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2279080-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
filingDate 2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c16c0ce1b6058a62b2cf99ff2a398226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c4e9773f4202eed998b5673df9d590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_840dcdba1344da4cec85df0182d3e09a
publicationDate 2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2279080-C1
titleOfInvention Method for evaluating indications in favor of drug therapy for treating children for obesity combined with insulin-resistance
abstract FIELD: medicine. n SUBSTANCE: method involves determining aqueous fraction ratio as hydration coefficient in capillary blood erythrocytes. The value being equal to or greater than 5.36, the state is considered to require drug therapy with Methformin. n EFFECT: enhanced effectiveness of treatment. n 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2619872-C1
priorityDate 2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684

Total number of triples: 17.